A new computing era arrives with the breakthrough in how computers can sort information. This vital function, at the heart of ...
A maker mapped neural inference into Minecraft’s redstone circuits, creating a 5-million-parameter “ChatGPT” in a sandbox ...
When copper debuted in Minecraft on June of 2021, it was immediately a block with tons of potential, thanks to the ability to ...
As lung cancer treatments evolve and more data are published, there is a need for updated recommendations on how to manage ...
Tech Trendsetters share their current projects to drive innovation in housing tech — from applied AI to tools that empower ...
Adults who use cannabis were more likely to develop type 2 diabetes than nonusers, according to findings presented at the European Association for the Study of Diabetes annual meeting. In an analysis ...
The chief executive of the SFA has told a Holyrood committee that a review into youth football in Scotland “will be published soon”. Ian Maxwell has urged clubs to “be more strategic” and used the ...
Shares in Raspberry Pi have tumbled, leaving investors questioning if one of the UK’s best tech IPOs can live up to ...
In 2025, US dollar faces renewed scrutiny as persistently high deficits, rising debt servicing costs and inflation around 3% ...
Icotrokinra demonstrated superior skin clearance at Weeks 16 and 24 compared to deucravacitinib and similar adverse event rates to placebo in Phase 3 ICONIC-ADVANCE studies.1 Icotrokinra also showed ...
Pharmaceutical Technology on MSN
UniQure stock surges 247% after mid-stage Huntington’s win
After demonstrating that its gene therapy can slash Huntington's disease progression by 75%, Uniqure will now file for ...
Enanta Pharmaceuticals remains a Buy as zelicapavir shows promise in RSV trials; strong financials support growth. Read why ENTA stock remains a Buy.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results